Research programme: marine microorganism-derived antibiotic - Piramal Healthcare
Alternative Names: PM-181104Latest Information Update: 16 Jul 2016
At a glance
- Originator Piramal Life Sciences
- Developer Piramal Enterprises
- Class Cyclic peptides
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Methicillin-resistant Staphylococcus aureus infections; Vancomycin-resistant enterococcal infections
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Methicillin-resistant-Staphylococcus-aureus-infections in India (Injection)
- 16 Jul 2016 No recent reports of development identified for preclinical development in Vancomycin-resistant-enterococcal-infections in India (Injection)